Difficulty: Medium
Average Score: 62%
Practice
Mrs. Franklin, an 81-year-old Alzheimer's patient hospitalized under your care has been asked to participate in a clinical trial testing a new drug designed to help improve memory. You were present when the clinical investigator obtained a signed informed consent from Mrs. Franklin a few days ago. However, when you visit Mrs. Franklin today and ask her if she is ready to begin the study tomorrow, she looks at you blankly and seems to have no idea what you are talking about. What should you do?
Correct answer
D
Rationale
Her current lack of understanding casts doubt on her consent; all steps are necessary to reassess her participation.